Part
01
of two
Part
01
Fertility Treatment Companies
The top ten companies in the U.S. field of natural/non-medication based or IVF fertility treatment are Thermo Fisher Scientific, Inc., EMD Serono, Inc., Coopersurgical, Inc., Progyny, Inc., Irvine Scientific, Hamilton Thorne, Inc., The Baker Company, Inc., Biogenics, ESCO Micro PTE, and Boston IVF.
Thermo Fisher Scientific, Inc.
- Revenue: $24,358 million.
EMD Serono, Inc.
- Revenue: $220.30 million.
Coopersurgical, Inc.
- Revenue: $2,532.8 million.
Progyny, Inc.
- Revenue: $105.4 million.
Irvine Scientific
- Revenue: $31.98 million.
Hamilton Thorne, Inc.
- Revenue: $29.21 million.
The Baker Company, Inc.
- Revenue: $28.15 million.
Biogenics
- Revenue: $8.4 million.
ESCO Micro PTE
- Revenue: $6.64 million.
- Note that while this company is headquartered in Singapore, it has locations in the U.S.
Boston IVF
- Revenue: $400,000
Research Strategy
To identify the top ten companies that provide natural/non-medication based or IVF fertility treatment in the U.S., your research team leveraged market reports from sources such as Markets&Markets and Market Data Forecast. These sources provided a host of key players in the global and North American IVF treatment market. From these lists, we proceeded to search for the revenue of companies that are located in the U.S., from which we have provided 10 of the companies with the highest annual revenue.
To identify the market share of these companies, we searched for any publication that has provided market share data of top players in the global IVF treatment market, but no such report was found. We also search through press media articles and publications by these companies hoping to find press releases or interviews granted by top officials from the company that hints on the share of these companies in the IVF market but no such report was found. Therefore, we resorted to triangulation to determine the market share of these companies. While the size of the U.S. IVF treatment market was not publicly available, we focused on the size of the North American market since it is dominated by the U.S. and Canada. However, the team could not continue with this attempt because some companies such as Thermo Fisher, Coopersurgical, Inc. offer a wide range of services and their annual report does not provide revenue data broken down by segment. Hence, using the general revenue of these companies to determine their market share in the IVF market would not represent the true share of the companies. For instance, while the 2019 size of the North American IVF market was about $760 million and the projected size of the global market is about $847.8 million by 2022, Thermo Fisher and Coopersurgical, Inc. generated $24 billion and $2 billion respectively from general sales and services in 2018 which is more than the global and North American market size for IVF.